Related Experiment Video
Updated: Oct 26, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Novel FHL1 Mutation Associated With Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and Myopathy
M Scott Binder1, Emily Brown2, Thomas Aversano2
1Department of Medicine, Johns Hopkins Bayview Medical Center, Johns Hopkins University, Baltimore, Maryland.
Insights
A novel mutation in the FHL1 gene was identified in a young man with hypertrophic cardiomyopathy and muscle cramps. This finding links FHL1 mutations to Emery-Dreifuss muscular dystrophy and sudden cardiac death risk.
Area of Science:
- Cardiology
- Genetics
- Neuromuscular Disorders
Background:
- Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death in young individuals.
- Genetic mutations are implicated in the pathogenesis of HCM and related cardiomyopathies.
- Emery-Dreifuss muscular dystrophy (EDMD) is a rare genetic disorder affecting skeletal muscles, heart, and contractures.
Abstract:
A 24-year-old man with muscle cramps and a family history of sudden death presented with palpitations. Electrocardiography showed signs of left ventricular hypertrophy and nonsustained ventricular tachycardia, and imaging studies confirmed hypertrophic cardiomyopathy. Genetic testing revealed a novel FHL1 mutation associated with Emery-Dreifuss muscular dystrophy. An implantable cardioverter-defibrillator was placed. (Level of Difficulty: Advanced.).
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy

